Associate Director, Study Start Up (Site Budgets & Contracts)

Start free →

Or apply yourself on the official page →

About the role

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets. About You You know clinical site budgets from the inside: how a protocol translates into procedures, how procedure-level benchmarks and institutional overheads differ by country, and where negotiations typically stall. You are comfortable holding a firm, well-reasoned position with a site while keeping the relationship intact, and you know when to escalate. You bring structure to complex, cross-functional study start up work and use data to shorten cycle times rather than just report on them. Position Overview Eikon Therapeutics is seeking an Associate Director, Site Budgets & Contracts to join our Study Start Up group within Clinical Operations. This role is the Clinical Operations global subject-matter lead for investigator site budgets and clinical trial agreements (CTAs) across our oncology portfolio. You will own the strategy, standards, and execution for building, benchmarking, and negotiating site budgets so that CTAs are executed rapidly, consistently, and with a defensible Fair Market Value (FMV) basis, enabling on-time site activation. Y ou will partner closely with Clinical Study Management, Legal, Finance, Regulatory, Data Management, and our contracting vendors, and you will be the escalation point for out-of-parameter budget and payment-term requests. This is a hands-on leadership role: you will negotiate directly on priority sites and studies while also setting the playbook that others follow. This role requires onsite presence at minimum 3 days per week to support effective management, operational excellence, and high-performance delivery of clinical studies and expected team growth & collaboration. Key Responsibilities Site Budget Strategy and Development • Serve as the global subject-matter expert and accountable owner for investigator site and country budget development across assigned oncology studies. • Interpret clinical protocols and schedules of assessment to build procedure-level site budgets, delineating standard-of-care versus research procedures and incorporating oncology-specific cost drivers (e.g., biopsies, biomarker and imaging assessments, patient stipends, drug handling). • Establish and govern global and country-specific budget templates, including benchmarking methodology, overhead and indirect-cost assumptions, and invoiceable-item conventions. • Develop, document, and maintain the FMV rationale for site budgets in an audit-ready manner, in alignment with anti-kickback, anti-bribery, and transparency requirements. Contract Negotiation and Execution • Lead budget and payment-term negotiations with investigator sites and institutions, directly on priority studies and sites and through oversight of CRO or vendor contracting teams. • Define and maintain negotiation parameters, authority limits, and an escalation matrix in partnership with Legal and Clinical Operations; serve as the escalation point for out-of-parameter budget and payment-term requests. • Coordinate CTA and budget finalization with Legal (legal language), Finance (payment terms and accruals), and the investigator payments and Clinical Data Management functions to ensure clean handoff and accurate site payment setup. • Drive rapid, high-quality CTA execution to meet site activation targets

View the official posting →